PER 3.85% 13.5¢ percheron therapeutics limited

SHORTFALL, page-46

  1. 3,205 Posts.
    lightbulb Created with Sketch. 571
    Yes the non dillutive funding comments (which may have been true at the time) havent helped MDs popularity.

    lets hope w CG there's a more honest path moving forward.

    They have stated 3 options with a timefra me which is nice to know.

    i do think a bank loan, paid back when our SP is much higher is the best option, outside selling acro which is dead wood.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.